China's Innocare Pharma plans virtual investor meetings for HK IPO

Photo: HKEX website

A Chinese biotech firm that canceled investor meetings for its Hong Kong initial public offering earlier this month due to the novel coronavirus outbreak is planning to hold them as soon as next week, but likely virtually.

In a sign of the disruptive impact of the epidemic — which has killed more than 2,600 people and infected 80,000 globally — is having on in-person dealmaking, InnoCare Pharma Ltd. is considering holding most of the meetings with prospective investors via video or phone calls, according to people familiar with the matter.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter